Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.

Hims alternatives: top 3 programs compared

If Hims isn't right for you — coverage, pricing, state availability, or program fit — these are the editorially-vetted alternatives we recommend. Editorial pick at #1.

Last reviewed: June 2026 · how we rank · original Hims review →

Editorial pick
Ro logo

Ro

from $2/mo
  • Best for clinical oversight

Ro — original online ED brand, sildenafil & tadalafil

Why we picked it

Cleaner clinical voice and quarterly auto-ship with reminders means less reorder friction once you've settled on a dose.

Who should skip

Skip if you want the lowest entry price — Hims undercuts Ro's starting tier.

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Entry price slightly above Hims
  • No chewable option

We may earn a commission. Pricing on partner site is final.

Why we pick this: Highest-ranked Hims alternative on our 5-factor methodology score.

BlueChew logo

BlueChew

from $20/mo

BlueChew — chewable sildenafil & tadalafil

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Costs 2-5× more than generic sildenafil at competitors
  • Not available in New York

We may earn a commission. Pricing on partner site is final.

REX MD logo

REX MD

from $25/mo

REX MD — men's health platform with same-day visits

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Single-category pricing is mid-pack
  • Unavailable in Louisiana

We may earn a commission. Pricing on partner site is final.

Why trust this comparison

Independent

No equity in any telehealth service. We earn affiliate commissions on click-through and never alter rankings for revenue.

Affiliate disclosure

Primary sources

Every clinical claim is cited to FDA labels, peer-reviewed trials with DOI links, or specialty-society guidelines. Never secondary sources.

Editorial methodology

Editorial-revenue separation

Commission rates do not affect ranking, scoring, or inclusion. We publish negative findings on paying affiliate partners.

Editorial policy

Compare Hims head-to-head